INFERIOR VENA CAVA (IVC) FILTER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global inferior vena cava (IVC) filter market growth is driven by rising incidence of deep vein thrombosis and pulmonary embolism. IVC filters are medical devices that are implanted in the inferior vena cava, the largest vein in the human body that carries deoxygenated blood from the lower half of the body to the heart. These filters are used to prevent life-threatening pulmonary embolism by blocking blood clots from traveling from the legs and pelvis to the lungs. With rapid growth in elderly population who are more susceptible to VTE disorders and growing awareness regarding prophylactic treatment options, there has been huge demand for IVC filters. Technological advancements presenting improved efficacy and safety can also drive the market growth.

Market Dynamics:

Global inferior vena cava (IVC) filter market growth is primarily driven by rising prevalence of venous thromboembolism (VTE) disorders such as deep vein thrombosis (DVT) and pulmonary embolism, growing geriatric population base susceptible to these conditions, growing awareness about prophylactic treatment options along with technological advancements presenting improved patient outcomes. However, risks and complications associated with IVC filter placement including device fracture, embolization and failure to capture blood clots completely can hamper the market growth. Emerging markets with growing medical infrastructure and healthcare spending can offer growth opportunities. Development of novel bio-absorbable and retrievable IVC filters can offer new growth opportunities.

Key features of the study:

- This report provides in-depth analysis of the global inferior vena cava (IVC) filter market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global inferior vena cava (IVC) filter market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include B. Braun Melsungen AG, Boston Scientific Corporation, Cardinal Health, Cook Medical, C.R. Bard, and Medtronic.

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global inferior vena cava (IVC) filter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inferior vena cava (IVC) filter market

Detailed Segmentation-

•  Product Type Insights (Revenue, USD Mn, 2019 - 2031)
• • Retrievable IVC Filters
  • Permanent IVC Filters
•  Material Insights (Revenue, USD Mn, 2019 - 2031)
• • Metal
  • Non-Metal
•  Placement Insights (Revenue, USD Mn, 2019 - 2031)
• • Suprarenal IVC Filters
  • Infrarenal IVC Filters
•  Application Insights (Revenue, USD Mn, 2019 - 2031)
• • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Trauma and Surgical Procedures
  • Others
•  End User Insights (Revenue, USD Mn, 2019 - 2031)
• • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
• Regional Insights (Revenue, USD Mn 2019 - 2031)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Boston Scientific Corporation
  • Cook Medical
  • Cardinal Health
  • C.R. Bard (acquired by BD)
  • ALN
  • Braun Melsungen
  • Braile Biomdica
  • VENITI
  • Argon Medical Devices
  • Koninklijke Philips
  • Mermaid Medical A/S
  • Becton Dickinson and Co
  • Cordis Corporation
  • Volcano Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Terumo Corporation
  • Merit Medical Systems
  • Lifetech Scientific Corporation